72 Recruiting Systemic Lupus Erythematosus Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Systemic Lupus Erythematosus
Related Conditions
Top Recruiting Systemic Lupus Erythematosus Studies
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
📍 Onyx Clinical Research — Peoria, Arizona
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus
📍 Pinnacle Research Group — Anniston, Alabama
View Study & Checklist ➔REACH (Restore Energy, Activity Can Help) Lupus Study
📍 Tufts Medical Center — Boston, Massachusetts
View Study & Checklist ➔Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice
📍 Research Site — Innsbruck, Tyrol
View Study & Checklist ➔A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
📍 Local Institution - 0012 — Birmingham, Alabama
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
📍 Local Institution - 0100 — Birmingham, Alabama
View Study & Checklist ➔A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
📍 Keck School of Medicine of University of Southern California — Los Angeles, California
View Study & Checklist ➔HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms
📍 NYU Langone Health — New York, New York
View Study & Checklist ➔A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
📍 Clinica De La Costa — Barranquilla,
View Study & Checklist ➔A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
📍 Accel Research Sites Network - Birmingham- Site Number : 8400003 — Vestavia Hills, Alabama
View Study & Checklist ➔Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Centrally Acting ACE Inhibition in SLE
📍 Yale University School of Medicine — New Haven, Connecticut
View Study & Checklist ➔Peer Approaches to Lupus Self-management
📍 Medical University of South Carolina — Charleston, South Carolina
View Study & Checklist ➔The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
📍 The Lundquist Institute at Harbor-UCLA Medical Center — Torrance, California
View Study & Checklist ➔Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
📍 GSK Investigational Site — Cincinnati, Ohio
View Study & Checklist ➔Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
📍 Pinnacle Research Group LLC — Anniston, Alabama
View Study & Checklist ➔A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
📍 Local Institution - 0035 — Aurora, Colorado
View Study & Checklist ➔Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
📍 AZ Arthritis and Rheumatology /ID# 261848 — Chandler, Arizona
View Study & Checklist ➔Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
📍 Pinnacle Research Group Llc — Anniston, Alabama
View Study & Checklist ➔A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
📍 Local Institution - 0063 — La Jolla, California
View Study & Checklist ➔REACT-01: Reversing Autoimmunity Through Cell Therapy
📍 Seattle Children's Hospital — Seattle, Washington
View Study & Checklist ➔Duke Lupus Registry
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔Intervention to Improve Communication and Medication Adherence in Lupus
📍 Duke University — Durham, North Carolina
View Study & Checklist ➔A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
📍 Gold Coast University Hospital ( Site 1601) — Southport, Queensland
View Study & Checklist ➔An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔Systemic Lupus Erythematosus in Gullah Health
📍 Medical University of South Carolina — Charleston, South Carolina
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
📍 Sl0044 50058 — Avondale, Arizona
View Study & Checklist ➔A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
📍 Climb Bio Investigative Site #100104 — Allen, Texas
View Study & Checklist ➔Anifrolumab Pregnancy Study
📍 Research Site — Cary, North Carolina
View Study & Checklist ➔Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
📍 University of California, Los Angeles — Los Angeles, California
View Study & Checklist ➔A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
📍 Pinnacle Research Group /ID# 278677 — Anniston, Alabama
View Study & Checklist ➔Study of Systemic Lupus Erythematosus
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Alnuctamab for Refractory SLE (LATTE Study)
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
📍 Research Site — Anniston, Alabama
View Study & Checklist ➔Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
📍 Northwestern University — Chicago, Illinois
View Study & Checklist ➔Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
📍 Pinnacle Research Group Llc — Anniston, Alabama
View Study & Checklist ➔A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
📍 HonorHealth Research and Innovation Institute — Scottsdale, Arizona
View Study & Checklist ➔